| Companies sponsors |
AbbVie (epcoritamab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| |
Welsh Government |
| Patient carer groups |
Blood Cancer UK |
| |
Lymphoma Action |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Associated public health groups |
None |
| Comparator companies |
Kite, a Gilead company (Axicabtagene ciloleucel) (confidentiality agreement signed, participating) |
| |
Accord Healthcare (bendamustine, carboplatin, cisplatin, cytarabine, epirubicin, etoposide, gemcitabine, oxaliplatin) (confidentiality agreement not signed, not participating) |
| |
Baxter Healthcare (cyclophosphamide, ifosfamide) (confidentiality agreement not signed, not participating) |
| |
Celgene, a BMS company (lenalidomide) (confidentiality agreement not signed, not participating) |
| |
Cheplapharm Arzneimittel GmbH (etoposide) (confidentiality agreement not signed, not participating) |
| |
Consilient Health (bendamustine) (confidentiality agreement not signed, not participating) |
| |
Dr Reddy’s Laboratories UK (bendamustine) (confidentiality agreement not signed, not participating) |
| |
Hospira UK (carboplatin, cisplatin, cytarabine, gemcitabine, oxaliplatin, vincristine) (confidentiality agreement not signed, not participating) |
| |
Incyte Biosciences (tafasitamab) (confidentiality agreement not signed, not participating) |
| |
Medac GmBH (epirubicin, etoposide, lomustine, oxaliplatin) (confidentiality agreement not signed, not participating) |
| |
Napp Pharmaceuticals (rituximab) (confidentiality agreement not signed, not participating) |
| |
Pfizer (cytarabine, epirubicin, rituximab) (confidentiality agreement not signed, not participating) |
| |
Roche Products (polatuzumab, rituximab) (confidentiality agreement not signed, not participating) |
| |
Sandoz (cisplatin, rituximab) (confidentiality agreement not signed, not participating) |
| |
Seacross pharmaceuticals (bendamustine, epirubicin, oxaliplatin) (confidentiality agreement not signed, not participating) |
| |
Servier Laboratories (pixantrone) (confidentiality agreement not signed, not participating) |
| |
Sun Pharmaceuticals (gemcitabine, oxaliplatin) (confidentiality agreement not signed, not participating) |
| |
Zentiva (bendamustine) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |